According to new survey, global Cancer Radiotherapy market is projected to reach US$ 7404 million in 2029, increasing from US$ 6011 million in 2022, with the CAGR of 3.2% during the period of 2023 to 2029.

Cancer Radiotherapy Market

Radiotherapy is a type of ionising radiation (high energy) that destroys the cancer cells in the treated area by damaging the DNA of these cells.

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cancer Radiotherapy market research.

The increasing prevalence of cancer globally, driven by factors such as aging populations and lifestyle changes, creates a higher demand for effective cancer treatment options, including radiotherapy.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cancer Radiotherapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Cancer Radiotherapy Market Report

Report Metric	Details
Report Name	Cancer Radiotherapy Market
Accounted market size in 2022	US$ 6011 million
Forecasted market size in 2029	US$ 7404 million
CAGR	3.2%
Base Year	2022
Forecasted years	2023 - 2029
Segment by Type	External Beam Radiotherapy Internal Beam Radiotherapy Systemic Radiotherapy Intravenous Radiotherapy Oral Radiotherapy Instillation Radiotherapy
Segment by Application	Hospitals Independent Radiotherapy Centers
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Siemens Healthineers, Elekta, Accuray Incorporated, IBA, ViewRay Technologies, Hitachi Ltd., iCAD, Inc., IsoRay, Mevion Medical Systems, Panacea Medical Technologies, P-cure Ltd., ZEISS Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

How fast is Cancer Radiotherapy Market growing?

Ans: The Cancer Radiotherapy Market witnessing a CAGR of 3.2% during the forecast period 2023-2029.

What is the Cancer Radiotherapy Market size in 2029?

Ans: The Cancer Radiotherapy Market size in 2029 will be US$ 7404 million.

Who are the main players in the Cancer Radiotherapy Market report?

Ans: The main players in the Cancer Radiotherapy Market are Siemens Healthineers, Elekta, Accuray Incorporated, IBA, ViewRay Technologies, Hitachi Ltd., iCAD, Inc., IsoRay, Mevion Medical Systems, Panacea Medical Technologies, P-cure Ltd., ZEISS Group

What are the Application segmentation covered in the Cancer Radiotherapy Market report?

Ans: The Applications covered in the Cancer Radiotherapy Market report are Hospitals, Independent Radiotherapy Centers

What are the Type segmentation covered in the Cancer Radiotherapy Market report?

Ans: The Types covered in the Cancer Radiotherapy Market report are External Beam Radiotherapy, Internal Beam Radiotherapy, Systemic Radiotherapy, Intravenous Radiotherapy, Oral Radiotherapy, Instillation Radiotherapy

1 Cancer Radiotherapy Market Overview

1.1 Product Overview and Scope of Cancer Radiotherapy

1.2 Cancer Radiotherapy Segment by Type

1.2.1 Global Cancer Radiotherapy Market Value Comparison by Type (2023-2029)

1.2.2 External Beam Radiotherapy

1.2.3 Internal Beam Radiotherapy

1.2.4 Systemic Radiotherapy

1.2.5 Intravenous Radiotherapy

1.2.6 Oral Radiotherapy

1.2.7 Instillation Radiotherapy

1.3 Cancer Radiotherapy Segment by Application

1.3.1 Global Cancer Radiotherapy Market Value by Application: (2023-2029)

1.3.2 Hospitals

1.3.3 Independent Radiotherapy Centers

1.4 Global Cancer Radiotherapy Market Size Estimates and Forecasts

1.4.1 Global Cancer Radiotherapy Revenue 2018-2029

1.4.2 Global Cancer Radiotherapy Sales 2018-2029

1.4.3 Global Cancer Radiotherapy Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2 Cancer Radiotherapy Market Competition by Manufacturers

2.1 Global Cancer Radiotherapy Sales Market Share by Manufacturers (2018-2023)

2.2 Global Cancer Radiotherapy Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Cancer Radiotherapy Average Price by Manufacturers (2018-2023)

2.4 Global Cancer Radiotherapy Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Cancer Radiotherapy, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Cancer Radiotherapy, Product Type & Application

2.7 Cancer Radiotherapy Market Competitive Situation and Trends

2.7.1 Cancer Radiotherapy Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Cancer Radiotherapy Players Market Share by Revenue

2.7.3 Global Cancer Radiotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Cancer Radiotherapy Retrospective Market Scenario by Region

3.1 Global Cancer Radiotherapy Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Cancer Radiotherapy Global Cancer Radiotherapy Sales by Region: 2018-2029

3.2.1 Global Cancer Radiotherapy Sales by Region: 2018-2023

3.2.2 Global Cancer Radiotherapy Sales by Region: 2024-2029

3.3 Global Cancer Radiotherapy Global Cancer Radiotherapy Revenue by Region: 2018-2029

3.3.1 Global Cancer Radiotherapy Revenue by Region: 2018-2023

3.3.2 Global Cancer Radiotherapy Revenue by Region: 2024-2029

3.4 North America Cancer Radiotherapy Market Facts & Figures by Country

3.4.1 North America Cancer Radiotherapy Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Cancer Radiotherapy Sales by Country (2018-2029)

3.4.3 North America Cancer Radiotherapy Revenue by Country (2018-2029)

3.4.4 United States

3.4.5 Canada

3.5 Europe Cancer Radiotherapy Market Facts & Figures by Country

3.5.1 Europe Cancer Radiotherapy Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Cancer Radiotherapy Sales by Country (2018-2029)

3.5.3 Europe Cancer Radiotherapy Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Cancer Radiotherapy Market Facts & Figures by Country

3.6.1 Asia Pacific Cancer Radiotherapy Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Cancer Radiotherapy Sales by Country (2018-2029)

3.6.3 Asia Pacific Cancer Radiotherapy Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Cancer Radiotherapy Market Facts & Figures by Country

3.7.1 Latin America Cancer Radiotherapy Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Cancer Radiotherapy Sales by Country (2018-2029)

3.7.3 Latin America Cancer Radiotherapy Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Cancer Radiotherapy Market Facts & Figures by Country

3.8.1 Middle East and Africa Cancer Radiotherapy Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Cancer Radiotherapy Sales by Country (2018-2029)

3.8.3 Middle East and Africa Cancer Radiotherapy Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Cancer Radiotherapy Sales by Type (2018-2029)

4.1.1 Global Cancer Radiotherapy Sales by Type (2018-2023)

4.1.2 Global Cancer Radiotherapy Sales by Type (2024-2029)

4.1.3 Global Cancer Radiotherapy Sales Market Share by Type (2018-2029)

4.2 Global Cancer Radiotherapy Revenue by Type (2018-2029)

4.2.1 Global Cancer Radiotherapy Revenue by Type (2018-2023)

4.2.2 Global Cancer Radiotherapy Revenue by Type (2024-2029)

4.2.3 Global Cancer Radiotherapy Revenue Market Share by Type (2018-2029)

4.3 Global Cancer Radiotherapy Price by Type (2018-2029)

5 Segment by Application

5.1 Global Cancer Radiotherapy Sales by Application (2018-2029)

5.1.1 Global Cancer Radiotherapy Sales by Application (2018-2023)

5.1.2 Global Cancer Radiotherapy Sales by Application (2024-2029)

5.1.3 Global Cancer Radiotherapy Sales Market Share by Application (2018-2029)

5.2 Global Cancer Radiotherapy Revenue by Application (2018-2029)

5.2.1 Global Cancer Radiotherapy Revenue by Application (2018-2023)

5.2.2 Global Cancer Radiotherapy Revenue by Application (2024-2029)

5.2.3 Global Cancer Radiotherapy Revenue Market Share by Application (2018-2029)

5.3 Global Cancer Radiotherapy Price by Application (2018-2029)

6 Key Companies Profiled

6.1 Siemens Healthineers

6.1.1 Siemens Healthineers Corporation Information

6.1.2 Siemens Healthineers Description and Business Overview

6.1.3 Siemens Healthineers Cancer Radiotherapy Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Siemens Healthineers Cancer Radiotherapy Product Portfolio

6.1.5 Siemens Healthineers Recent Developments/Updates

6.2 Elekta

6.2.1 Elekta Corporation Information

6.2.2 Elekta Description and Business Overview

6.2.3 Elekta Cancer Radiotherapy Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Elekta Cancer Radiotherapy Product Portfolio

6.2.5 Elekta Recent Developments/Updates

6.3 Accuray Incorporated

6.3.1 Accuray Incorporated Corporation Information

6.3.2 Accuray Incorporated Description and Business Overview

6.3.3 Accuray Incorporated Cancer Radiotherapy Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Accuray Incorporated Cancer Radiotherapy Product Portfolio

6.3.5 Accuray Incorporated Recent Developments/Updates

6.4 IBA

6.4.1 IBA Corporation Information

6.4.2 IBA Description and Business Overview

6.4.3 IBA Cancer Radiotherapy Sales, Revenue and Gross Margin (2018-2023)

6.4.4 IBA Cancer Radiotherapy Product Portfolio

6.4.5 IBA Recent Developments/Updates

6.5 ViewRay Technologies

6.5.1 ViewRay Technologies Corporation Information

6.5.2 ViewRay Technologies Description and Business Overview

6.5.3 ViewRay Technologies Cancer Radiotherapy Sales, Revenue and Gross Margin (2018-2023)

6.5.4 ViewRay Technologies Cancer Radiotherapy Product Portfolio

6.5.5 ViewRay Technologies Recent Developments/Updates

6.6 Hitachi Ltd.

6.6.1 Hitachi Ltd. Corporation Information

6.6.2 Hitachi Ltd. Description and Business Overview

6.6.3 Hitachi Ltd. Cancer Radiotherapy Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Hitachi Ltd. Cancer Radiotherapy Product Portfolio

6.6.5 Hitachi Ltd. Recent Developments/Updates

6.7 iCAD, Inc.

6.6.1 iCAD, Inc. Corporation Information

6.6.2 iCAD, Inc. Description and Business Overview

6.6.3 iCAD, Inc. Cancer Radiotherapy Sales, Revenue and Gross Margin (2018-2023)

6.4.4 iCAD, Inc. Cancer Radiotherapy Product Portfolio

6.7.5 iCAD, Inc. Recent Developments/Updates

6.8 IsoRay

6.8.1 IsoRay Corporation Information

6.8.2 IsoRay Description and Business Overview

6.8.3 IsoRay Cancer Radiotherapy Sales, Revenue and Gross Margin (2018-2023)

6.8.4 IsoRay Cancer Radiotherapy Product Portfolio

6.8.5 IsoRay Recent Developments/Updates

6.9 Mevion Medical Systems

6.9.1 Mevion Medical Systems Corporation Information

6.9.2 Mevion Medical Systems Description and Business Overview

6.9.3 Mevion Medical Systems Cancer Radiotherapy Sales, Revenue and Gross Margin (2018-2023)

6.9.4 Mevion Medical Systems Cancer Radiotherapy Product Portfolio

6.9.5 Mevion Medical Systems Recent Developments/Updates

6.10 Panacea Medical Technologies

6.10.1 Panacea Medical Technologies Corporation Information

6.10.2 Panacea Medical Technologies Description and Business Overview

6.10.3 Panacea Medical Technologies Cancer Radiotherapy Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Panacea Medical Technologies Cancer Radiotherapy Product Portfolio

6.10.5 Panacea Medical Technologies Recent Developments/Updates

6.11 P-cure Ltd.

6.11.1 P-cure Ltd. Corporation Information

6.11.2 P-cure Ltd. Cancer Radiotherapy Description and Business Overview

6.11.3 P-cure Ltd. Cancer Radiotherapy Sales, Revenue and Gross Margin (2018-2023)

6.11.4 P-cure Ltd. Cancer Radiotherapy Product Portfolio

6.11.5 P-cure Ltd. Recent Developments/Updates

6.12 ZEISS Group

6.12.1 ZEISS Group Corporation Information

6.12.2 ZEISS Group Cancer Radiotherapy Description and Business Overview

6.12.3 ZEISS Group Cancer Radiotherapy Sales, Revenue and Gross Margin (2018-2023)

6.12.4 ZEISS Group Cancer Radiotherapy Product Portfolio

6.12.5 ZEISS Group Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Cancer Radiotherapy Industry Chain Analysis

7.2 Cancer Radiotherapy Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Cancer Radiotherapy Production Mode & Process

7.4 Cancer Radiotherapy Sales and Marketing

7.4.1 Cancer Radiotherapy Sales Channels

7.4.2 Cancer Radiotherapy Distributors

7.5 Cancer Radiotherapy Customers

8 Cancer Radiotherapy Market Dynamics

8.1 Cancer Radiotherapy Industry Trends

8.2 Cancer Radiotherapy Market Drivers

8.3 Cancer Radiotherapy Market Challenges

8.4 Cancer Radiotherapy Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Mevion Medical Systems

Panacea Medical Technologies

P-Cure Ltd.

Zeiss Group

List of Tables

Table 1. Global Cancer Radiotherapy Market Value Comparison by Type (2023-2029) & (US$ Million)

Table 2. Global Cancer Radiotherapy Market Value Comparison by Application (2023-2029) & (US$ Million)

Table 3. Global Cancer Radiotherapy Market Competitive Situation by Manufacturers in 2022

Table 4. Global Cancer Radiotherapy Sales (K Units) of Key Manufacturers (2018-2023)

Table 5. Global Cancer Radiotherapy Sales Market Share by Manufacturers (2018-2023)

Table 6. Global Cancer Radiotherapy Revenue (US$ Million) by Manufacturers (2018-2023)

Table 7. Global Cancer Radiotherapy Revenue Share by Manufacturers (2018-2023)

Table 8. Global Market Cancer Radiotherapy Average Price (US$/Unit) of Key Manufacturers (2018-2023)

Table 9. Global Key Players of Cancer Radiotherapy, Industry Ranking, 2021 VS 2022 VS 2023

Table 10. Global Key Manufacturers of Cancer Radiotherapy, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Cancer Radiotherapy, Product Type & Application

Table 12. Global Key Manufacturers of Cancer Radiotherapy, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Cancer Radiotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Radiotherapy as of 2022)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Cancer Radiotherapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

Table 17. Global Cancer Radiotherapy Sales by Region (2018-2023) & (K Units)

Table 18. Global Cancer Radiotherapy Sales Market Share by Region (2018-2023)

Table 19. Global Cancer Radiotherapy Sales by Region (2024-2029) & (K Units)

Table 20. Global Cancer Radiotherapy Sales Market Share by Region (2024-2029)

Table 21. Global Cancer Radiotherapy Revenue by Region (2018-2023) & (US$ Million)

Table 22. Global Cancer Radiotherapy Revenue Market Share by Region (2018-2023)

Table 23. Global Cancer Radiotherapy Revenue by Region (2024-2029) & (US$ Million)

Table 24. Global Cancer Radiotherapy Revenue Market Share by Region (2024-2029)

Table 25. North America Cancer Radiotherapy Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 26. North America Cancer Radiotherapy Sales by Country (2018-2023) & (K Units)

Table 27. North America Cancer Radiotherapy Sales by Country (2024-2029) & (K Units)

Table 28. North America Cancer Radiotherapy Revenue by Country (2018-2023) & (US$ Million)

Table 29. North America Cancer Radiotherapy Revenue by Country (2024-2029) & (US$ Million)

Table 30. Europe Cancer Radiotherapy Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 31. Europe Cancer Radiotherapy Sales by Country (2018-2023) & (K Units)

Table 32. Europe Cancer Radiotherapy Sales by Country (2024-2029) & (K Units)

Table 33. Europe Cancer Radiotherapy Revenue by Country (2018-2023) & (US$ Million)

Table 34. Europe Cancer Radiotherapy Revenue by Country (2024-2029) & (US$ Million)

Table 35. Asia Pacific Cancer Radiotherapy Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

Table 36. Asia Pacific Cancer Radiotherapy Sales by Region (2018-2023) & (K Units)

Table 37. Asia Pacific Cancer Radiotherapy Sales by Region (2024-2029) & (K Units)

Table 38. Asia Pacific Cancer Radiotherapy Revenue by Region (2018-2023) & (US$ Million)

Table 39. Asia Pacific Cancer Radiotherapy Revenue by Region (2024-2029) & (US$ Million)

Table 40. Latin America Cancer Radiotherapy Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 41. Latin America Cancer Radiotherapy Sales by Country (2018-2023) & (K Units)

Table 42. Latin America Cancer Radiotherapy Sales by Country (2024-2029) & (K Units)

Table 43. Latin America Cancer Radiotherapy Revenue by Country (2018-2023) & (US$ Million)

Table 44. Latin America Cancer Radiotherapy Revenue by Country (2024-2029) & (US$ Million)

Table 45. Middle East & Africa Cancer Radiotherapy Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 46. Middle East & Africa Cancer Radiotherapy Sales by Country (2018-2023) & (K Units)

Table 47. Middle East & Africa Cancer Radiotherapy Sales by Country (2024-2029) & (K Units)

Table 48. Middle East & Africa Cancer Radiotherapy Revenue by Country (2018-2023) & (US$ Million)

Table 49. Middle East & Africa Cancer Radiotherapy Revenue by Country (2024-2029) & (US$ Million)

Table 50. Global Cancer Radiotherapy Sales (K Units) by Type (2018-2023)

Table 51. Global Cancer Radiotherapy Sales (K Units) by Type (2024-2029)

Table 52. Global Cancer Radiotherapy Sales Market Share by Type (2018-2023)

Table 53. Global Cancer Radiotherapy Sales Market Share by Type (2024-2029)

Table 54. Global Cancer Radiotherapy Revenue (US$ Million) by Type (2018-2023)

Table 55. Global Cancer Radiotherapy Revenue (US$ Million) by Type (2024-2029)

Table 56. Global Cancer Radiotherapy Revenue Market Share by Type (2018-2023)

Table 57. Global Cancer Radiotherapy Revenue Market Share by Type (2024-2029)

Table 58. Global Cancer Radiotherapy Price (US$/Unit) by Type (2018-2023)

Table 59. Global Cancer Radiotherapy Price (US$/Unit) by Type (2024-2029)

Table 60. Global Cancer Radiotherapy Sales (K Units) by Application (2018-2023)

Table 61. Global Cancer Radiotherapy Sales (K Units) by Application (2024-2029)

Table 62. Global Cancer Radiotherapy Sales Market Share by Application (2018-2023)

Table 63. Global Cancer Radiotherapy Sales Market Share by Application (2024-2029)

Table 64. Global Cancer Radiotherapy Revenue (US$ Million) by Application (2018-2023)

Table 65. Global Cancer Radiotherapy Revenue (US$ Million) by Application (2024-2029)

Table 66. Global Cancer Radiotherapy Revenue Market Share by Application (2018-2023)

Table 67. Global Cancer Radiotherapy Revenue Market Share by Application (2024-2029)

Table 68. Global Cancer Radiotherapy Price (US$/Unit) by Application (2018-2023)

Table 69. Global Cancer Radiotherapy Price (US$/Unit) by Application (2024-2029)

Table 70. Siemens Healthineers Corporation Information

Table 71. Siemens Healthineers Description and Business Overview

Table 72. Siemens Healthineers Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 73. Siemens Healthineers Cancer Radiotherapy Product

Table 74. Siemens Healthineers Recent Developments/Updates

Table 75. Elekta Corporation Information

Table 76. Elekta Description and Business Overview

Table 77. Elekta Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 78. Elekta Cancer Radiotherapy Product

Table 79. Elekta Recent Developments/Updates

Table 80. Accuray Incorporated Corporation Information

Table 81. Accuray Incorporated Description and Business Overview

Table 82. Accuray Incorporated Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 83. Accuray Incorporated Cancer Radiotherapy Product

Table 84. Accuray Incorporated Recent Developments/Updates

Table 85. IBA Corporation Information

Table 86. IBA Description and Business Overview

Table 87. IBA Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 88. IBA Cancer Radiotherapy Product

Table 89. IBA Recent Developments/Updates

Table 90. ViewRay Technologies Corporation Information

Table 91. ViewRay Technologies Description and Business Overview

Table 92. ViewRay Technologies Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 93. ViewRay Technologies Cancer Radiotherapy Product

Table 94. ViewRay Technologies Recent Developments/Updates

Table 95. Hitachi Ltd. Corporation Information

Table 96. Hitachi Ltd. Description and Business Overview

Table 97. Hitachi Ltd. Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 98. Hitachi Ltd. Cancer Radiotherapy Product

Table 99. Hitachi Ltd. Recent Developments/Updates

Table 100. iCAD, Inc. Corporation Information

Table 101. iCAD, Inc. Description and Business Overview

Table 102. iCAD, Inc. Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 103. iCAD, Inc. Cancer Radiotherapy Product

Table 104. iCAD, Inc. Recent Developments/Updates

Table 105. IsoRay Corporation Information

Table 106. IsoRay Description and Business Overview

Table 107. IsoRay Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 108. IsoRay Cancer Radiotherapy Product

Table 109. IsoRay Recent Developments/Updates

Table 110. Mevion Medical Systems Corporation Information

Table 111. Mevion Medical Systems Description and Business Overview

Table 112. Mevion Medical Systems Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 113. Mevion Medical Systems Cancer Radiotherapy Product

Table 114. Mevion Medical Systems Recent Developments/Updates

Table 115. Panacea Medical Technologies Corporation Information

Table 116. Panacea Medical Technologies Description and Business Overview

Table 117. Panacea Medical Technologies Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 118. Panacea Medical Technologies Cancer Radiotherapy Product

Table 119. Panacea Medical Technologies Recent Developments/Updates

Table 120. P-cure Ltd. Corporation Information

Table 121. P-cure Ltd. Description and Business Overview

Table 122. P-cure Ltd. Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 123. P-cure Ltd. Cancer Radiotherapy Product

Table 124. P-cure Ltd. Recent Developments/Updates

Table 125. ZEISS Group Corporation Information

Table 126. ZEISS Group Description and Business Overview

Table 127. ZEISS Group Cancer Radiotherapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 128. ZEISS Group Cancer Radiotherapy Product

Table 129. ZEISS Group Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. Cancer Radiotherapy Distributors List

Table 133. Cancer Radiotherapy Customers List

Table 134. Cancer Radiotherapy Market Trends

Table 135. Cancer Radiotherapy Market Drivers

Table 136. Cancer Radiotherapy Market Challenges

Table 137. Cancer Radiotherapy Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Cancer Radiotherapy

Figure 2. Global Cancer Radiotherapy Market Value Comparison by Type (2023-2029) & (US$ Million)

Figure 3. Global Cancer Radiotherapy Market Share by Type in 2022 & 2029

Figure 4. External Beam Radiotherapy Product Picture

Figure 5. Internal Beam Radiotherapy Product Picture

Figure 6. Systemic Radiotherapy Product Picture

Figure 7. Intravenous Radiotherapy Product Picture

Figure 8. Oral Radiotherapy Product Picture

Figure 9. Instillation Radiotherapy Product Picture

Figure 10. Global Cancer Radiotherapy Market Value Comparison by Application (2023-2029) & (US$ Million)

Figure 11. Global Cancer Radiotherapy Market Share by Application in 2022 & 2029

Figure 12. Hospitals

Figure 13. Independent Radiotherapy Centers

Figure 14. Global Cancer Radiotherapy Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 15. Global Cancer Radiotherapy Market Size (2018-2029) & (US$ Million)

Figure 16. Global Cancer Radiotherapy Sales (2018-2029) & (K Units)

Figure 17. Global Cancer Radiotherapy Average Price (US$/Unit) & (2018-2029)

Figure 18. Cancer Radiotherapy Report Years Considered

Figure 19. Cancer Radiotherapy Sales Share by Manufacturers in 2022

Figure 20. Global Cancer Radiotherapy Revenue Share by Manufacturers in 2022

Figure 21. The Global 5 and 10 Largest Cancer Radiotherapy Players: Market Share by Revenue in 2022

Figure 22. Cancer Radiotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 23. Global Cancer Radiotherapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

Figure 24. North America Cancer Radiotherapy Sales Market Share by Country (2018-2029)

Figure 25. North America Cancer Radiotherapy Revenue Market Share by Country (2018-2029)

Figure 26. United States Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 27. Canada Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 28. Europe Cancer Radiotherapy Sales Market Share by Country (2018-2029)

Figure 29. Europe Cancer Radiotherapy Revenue Market Share by Country (2018-2029)

Figure 30. Germany Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 31. France Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 32. U.K. Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 33. Italy Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 34. Russia Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 35. Asia Pacific Cancer Radiotherapy Sales Market Share by Region (2018-2029)

Figure 36. Asia Pacific Cancer Radiotherapy Revenue Market Share by Region (2018-2029)

Figure 37. China Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 38. Japan Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 39. South Korea Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 40. India Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 41. Australia Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 42. China Taiwan Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 43. Indonesia Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 44. Thailand Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 45. Malaysia Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 46. Latin America Cancer Radiotherapy Sales Market Share by Country (2018-2029)

Figure 47. Latin America Cancer Radiotherapy Revenue Market Share by Country (2018-2029)

Figure 48. Mexico Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 49. Brazil Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 50. Argentina Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 51. Middle East & Africa Cancer Radiotherapy Sales Market Share by Country (2018-2029)

Figure 52. Middle East & Africa Cancer Radiotherapy Revenue Market Share by Country (2018-2029)

Figure 53. Turkey Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 54. Saudi Arabia Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 55. UAE Cancer Radiotherapy Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 56. Global Sales Market Share of Cancer Radiotherapy by Type (2018-2029)

Figure 57. Global Revenue Market Share of Cancer Radiotherapy by Type (2018-2029)

Figure 58. Global Cancer Radiotherapy Price (US$/Unit) by Type (2018-2029)

Figure 59. Global Sales Market Share of Cancer Radiotherapy by Application (2018-2029)

Figure 60. Global Revenue Market Share of Cancer Radiotherapy by Application (2018-2029)

Figure 61. Global Cancer Radiotherapy Price (US$/Unit) by Application (2018-2029)

Figure 62. Cancer Radiotherapy Value Chain

Figure 63. Cancer Radiotherapy Production Process

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Distributors Profiles

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pediatric Cardiac Tumor Diagnostic Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-6G6046

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Interventional Oncology Device Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-20U7613

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Colon Cancer Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-31C5944

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global CAR T-Cell Immunotherapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-10J13802

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions